A Comparative Clinical Study to Evaluate the Efficacy of Jeeraka Avaleha in Raktapradara
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 40
- 试验地点
- 1
- 主要终点
- The effect of treatment will be assessed on the
研究概览
简要总结
Among the gynecological disorders, Raktapradara is frequent complaint and the incidence has become higher with degree of civilization. If this condition is not treated, it will lead to complications like infertility, anemia, endometrial malignancy. According to modern, hormonal methods are the first line in medical management. Unfortunately, many options can be associated with hormonal side effects, prevention of fertility and lack of efficacy, leading to discontinuation and progression to surgical interventions. Thus, to avoid it Jeeraka Avalehain Yogatarangini, Pradara Adhyaya has been mentioned as excellent medicine in RaktapradaraIt has drugs which contain Stambana, Artavajanana, Shulahara, Angamarda Prashamana, Pandugna etc properties. It also has the drugs whose phytochemicals show anti-inflammatory, anti-oxidant, analgesic, antispasmodic action and can also be easily palatable. therefore an attempt is made to study the clinical evaluation of Jeeraka Avaleha in the management of raktapradara and compare its efficacy with the Pushyanuga choorna.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- None
入排标准
- 年龄范围
- 15.00 Year(s) 至 45.00 Year(s)（—）
- 性别
- Female
入选标准
- •Patients fulfilling diagnostic criteria 2)Patients will be selected in the age group of 15 to 45 years.
- •Patient with Hb more than 8-gram percent 4)Both married and unmarried women 5)Patient having excessive bleeding/prolonged bleeding/intermenstrual bleeding with the history of minimum of 2 cycles.
排除标准
- •Patient with the history of bleeding disorders, DM, HTN, TB.
- •Endocrinal disorders like Thyroid Dysfunction, PCOS.
- •IUCD, OCP 4)Any benign or malignant growth in reproductive tract.
- •PID, Endometriosis, Adenomyosis, Uterine Fibroids, Uterine polyp.
- •If any Anatomical defects.
结局指标
主要结局
The effect of treatment will be assessed on the
时间窗: Assessment will be done on 4th day, 7th day and 11th day of the cycle during the period of treatment for 2 consecutive cycles.
basis of subjective criteria
时间窗: Assessment will be done on 4th day, 7th day and 11th day of the cycle during the period of treatment for 2 consecutive cycles.
1.Anruthau Alpam Api- Intermenstrual Scanty Bleeding
时间窗: Assessment will be done on 4th day, 7th day and 11th day of the cycle during the period of treatment for 2 consecutive cycles.
2.Vedana – Pain
时间窗: Assessment will be done on 4th day, 7th day and 11th day of the cycle during the period of treatment for 2 consecutive cycles.
objective criteria
时间窗: Assessment will be done on 4th day, 7th day and 11th day of the cycle during the period of treatment for 2 consecutive cycles.
1) Duration of menstrual flow
时间窗: Assessment will be done on 4th day, 7th day and 11th day of the cycle during the period of treatment for 2 consecutive cycles.
2) Amount of menstrual flow (Pictorial blood loss assessment)
时间窗: Assessment will be done on 4th day, 7th day and 11th day of the cycle during the period of treatment for 2 consecutive cycles.
3) Interval between cycles
时间窗: Assessment will be done on 4th day, 7th day and 11th day of the cycle during the period of treatment for 2 consecutive cycles.
次要结局
- after treatment assessment will be done on the(basis of)
研究者
Dr Saniya Mahammedsab Sanadi
Alvas Ayurveda Medical College and Hospital Moodubidire